Dow Down3.39% Nasdaq Down4.12%

More On IBT.V

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


IBEX Technologies, Inc. (IBT.V)

-TSXV
0.14 Down 0.01(3.57%) Jun 24, 2:00PM EDT
ProfileGet Profile for:
IBEX Technologies, Inc.
5485 Pare Street
Suite 100
Montreal, QC H4P 1P7
Canada - Map
Phone: 514-344-4004
Fax: 514-344-8827
Website: http://www.ibex.ca

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

IBEX Technologies Inc., through its subsidiaries, manufactures and markets proteins for biomedical use in Canada, the United States, Europe, and internationally. The company produces a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B. It also manufactures and markets a series of arthritis assays, which are used in osteoarthritis research; and a series of arthritis biomarkers. The company is based in Montreal, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on IBEX Technologies, Inc.

Key Executives 
 PayExercised
Mr. Paul Baehr , 73
Chairman, Chief Exec. Officer and Pres
209.00K0.00
Mr. Richard Collin CPA-CA,
Director of Fin. and Sec.
116.00K0.00
Mr. Claire Bergeron ,
VP of Admin.
N/AN/A
Ms. Catherine Poulin ,
VP of Manufacturing
N/AN/A
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.